Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus
Related Posts
Goodman MT, Lombardi C, Torrens A, Bresee C, Saloman JL, Li L, Yang Y, Fisher WE, Fogel EL, Forsmark CE, Conwell DL, Hart PA, Park[...]
Chowdhury S, Sen A, Das D, Chakrabarti P. Deubiquitinase JOSD1 tempers hepatic proteotoxicity. Cell Death Discov. 2024 Sep 16;10(1):405. doi: 10.1038/s41420-024-02177-y. PMID: 39284830.
Wong CR, Crespi CM, Glenn B, May FP, Han SB, Bastani R, Macinko JA. Prevalence of Healthcare Barriers Among US Adults With Chronic Liver Disease[...]